Twenty percent of individuals at clinical high risk for psychosis (CHR-P) develop the disorder
within 2 years. Extensive research has explored the factors that differentiate those who …

With new data about different aspects of schizophrenia being continually generated, it
becomes necessary to periodically revisit exactly what we know. Along with a need to review …

The impact of the COVID-19 pandemic on psychosis remains to be established. Here we
report 6 cases (3 male and 3 female) of first-episode psychosis (FEP) admitted to our …

Importance Since the release of theDSM-5diagnosis of attenuated psychosis syndrome
(DSM-5–APS) in 2013, several research studies have investigated its clinical validity …

Accurate prognostication of individuals at clinical high-risk for psychosis (CHR-P) is an
essential initial step for effective primary indicated prevention. We aimed to summarise the …

Negative symptoms (such as amotivation and diminished expression) associated with
schizophrenia are a major health concern. Adequate treatment would mean important …

Background: The first rate-limiting step for improving outcomes of psychosis through
preventive interventions in people at clinical high risk for psychosis (CHR-P) is the ability to …

Primary prevention in individuals at Clinical High Risk for psychosis (CHR-P) can ameliorate
the course of psychotic disorders. Further advancements of knowledge have been slowed …

Recent evidence has suggested that psychosis could develop not only in people at clinical
high risk for psychosis (CHR-P) but also in those with clinical risk syndromes for emergent …

This book focuses on autism spectrum disorder (ASD) in the criminal justice system. Rather
than being the perpetrators of offending behaviour, individuals with ASD are more likely to …